Brian Mann | Connecticut Public Radio
WNPR

Brian Mann

A federal bankruptcy judge approved a controversial $8.3 billion settlement late Tuesday between Purdue Pharma and the Department of Justice.

The deal first unveiled last month stems from the company's decades-long manufacture and marketing of Oxycontin and other highly addictive opioid medications.

Under terms approved by Judge Robert Drain, Purdue Pharma will plead guilty to three felony counts of criminal wrongdoing.

Copyright 2020 NPR. To see more, visit https://www.npr.org.

ARI SHAPIRO, HOST: